Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

HCC in the Setting of Hepatitis B: Asia-Pacific Considerations

Grace LH Wong, MD
Released: June 8, 2021

Epidemiology of HCC

Epidemiology of HCC

In fact, approximately 80% of HCC cases worldwide can be attributed to chronic infection with either hepatitis B virus (HBV) or hepatitis C virus (HCV). These infections, particularly when left untreated, lead to cirrhosis, which is present in 80% to 90% of patients with HCC. Furthermore, because most HCC cases occur in countries with fewer healthcare resources (and, therefore, fewer surveillance options), HCC is often discovered at an advanced stage and accompanied by liver dysfunction, making this a highly lethal cancer.

Approximately 5% of the global population is infected with HBV, and 75% of patients with HBV are Asian. Within HBV endemic areas of the Asia-Pacific region, HBV infection is frequently acquired through mother-to-child transmission, which contributes to earlier onset of HCC than in nonendemic areas.3,4

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue